Aradigm Health CEO Will Shrank discusses the shift in value-based care models for cell and gene therapies. While advances in ...

Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...

Pharmaceutical Executive spoke with Aradigm Health CEO Will Shrank at the Asembia ASX26 Summit in Las Vegas. During the conversation, he explained the issues the payers face with cell & gene therapies ...

Understanding how wounds heal after injury could be a step closer thanks to a new mathematical model developed by researchers ...

Learn how to safely swap your AirTag's CR2032 cell and why certain child-safe coatings will stop your AirTag from working.

As trade policy, regulatory scrutiny, and capital discipline reshape biologics development, sponsors are rethinking where and ...

Rice researchers have developed extremely stable perovskite crystalline films for long-lasting, high-efficiency solar cells.

Bridging the gap between theory and reality, material testing transforms dense technical specifications into the physical ...

Globally, and particularly in the U.S., new frameworks are creating genuine opportunities for earlier collaboration.

A Colorado teacher is teaching high school students to use AI tools like Google Notebook LM to deepen their learning.

Crown Castle announced the successful close of the transaction to sell its Fiber Solutions business to Zayo Group and its ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army ...